HALO Annual Operating Margin
40.71%
+0.18%+0.44%
31 December 2023
Summary:
As of January 22, 2025, HALO annual operating profit margin is 40.71%, with the most recent change of +0.18% (+0.44%) on December 31, 2023. During the last 3 years, it has fallen by -13.20% (-24.49%). HALO annual operating margin is now -34.59% below its all-time high of 62.24%, reached on December 31, 2021.HALO Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Quarterly Operating Margin
56.26%
+5.59%+11.03%
30 September 2024
Summary:
As of January 22, 2025, HALO quarterly operating profit margin is 56.26%, with the most recent change of +5.59% (+11.03%) on September 30, 2024. Over the past year, it has increased by +15.40% (+37.69%). HALO quarterly operating margin is now -17.50% below its all-time high of 68.19%, reached on June 30, 2021.HALO Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Operating Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.4% | +37.7% |
3 y3 years | -24.5% | +37.7% |
5 y5 years | +189.2% | +37.7% |
HALO Operating Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -34.6% | +0.4% | -12.8% | +151.7% |
5 y | 5-year | -34.6% | +218.0% | -17.5% | +194.2% |
alltime | all time | -34.6% | +100.4% | -17.5% | +100.4% |
Halozyme Therapeutics Operating Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 56.26%(+11.0%) |
June 2024 | - | 50.67%(+3.9%) |
Mar 2024 | - | 48.78%(+11.1%) |
Dec 2023 | 40.71%(+0.4%) | 43.92%(+7.5%) |
Sept 2023 | - | 40.86%(-4.4%) |
June 2023 | - | 42.73%(+28.8%) |
Mar 2023 | - | 33.18%(-19.2%) |
Dec 2022 | 40.53%(-34.9%) | 41.05%(+3.0%) |
Sept 2022 | - | 39.86%(+78.3%) |
June 2022 | - | 22.35%(-65.4%) |
Mar 2022 | - | 64.52%(+16.4%) |
Dec 2021 | 62.24%(+15.5%) | 55.42%(-15.1%) |
Sept 2021 | - | 65.26%(-4.3%) |
June 2021 | - | 68.19%(+19.7%) |
Mar 2021 | - | 56.99%(-10.6%) |
Dec 2020 | 53.91%(-256.3%) | 63.78%(+3.4%) |
Sept 2020 | - | 61.70%(+15.3%) |
June 2020 | - | 53.52%(-521.1%) |
Mar 2020 | - | -12.71%(-78.7%) |
Dec 2019 | -34.50%(-24.4%) | -59.74%(+12.5%) |
Sept 2019 | - | -53.08%(+48.7%) |
June 2019 | - | -35.70%(-785.2%) |
Mar 2019 | - | 5.21%(-4441.7%) |
Dec 2018 | -45.65%(-278.5%) | -0.12%(-99.9%) |
Sept 2018 | - | -99.68%(+74.8%) |
June 2018 | - | -57.02%(-25.8%) |
Mar 2018 | - | -76.81%(-215.6%) |
Dec 2017 | 25.58%(-145.1%) | 66.43%(+424.3%) |
Sept 2017 | - | 12.67%(-116.8%) |
June 2017 | - | -75.49%(-18.9%) |
Mar 2017 | - | -93.09%(+60.8%) |
Dec 2016 | -56.72%(+179.0%) | -57.88%(-18.9%) |
Sept 2016 | - | -71.40%(+9.6%) |
June 2016 | - | -65.16%(+71.2%) |
Mar 2016 | - | -38.05%(-463.8%) |
Dec 2015 | -20.33%(-75.7%) | 10.46%(-109.4%) |
Sept 2015 | - | -111.82%(-1246.9%) |
June 2015 | - | 9.75%(-113.1%) |
Mar 2015 | - | -74.53%(+487.8%) |
Dec 2014 | -83.68% | -12.68%(-90.3%) |
Sept 2014 | - | -130.26%(+60.3%) |
Date | Annual | Quarterly |
---|---|---|
June 2014 | - | -81.26%(-61.4%) |
Mar 2014 | - | -210.76%(+23.5%) |
Dec 2013 | -146.78%(+15.8%) | -170.62%(+47.7%) |
Sept 2013 | - | -115.49%(-24.5%) |
June 2013 | - | -153.04%(-2.1%) |
Mar 2013 | - | -156.29%(+672.9%) |
Dec 2012 | -126.70%(+258.2%) | -20.22%(-94.6%) |
Sept 2012 | - | -375.49%(+107.3%) |
June 2012 | - | -181.10%(-11.0%) |
Mar 2012 | - | -203.50%(-73.4%) |
Dec 2011 | -35.37%(-91.1%) | -764.28%(-3502.8%) |
Sept 2011 | - | 22.46%(+68.2%) |
June 2011 | - | 13.35%(-110.4%) |
Mar 2011 | - | -128.05%(-74.4%) |
Dec 2010 | -398.25%(-6.9%) | -500.59%(+36.7%) |
Sept 2010 | - | -366.07%(-3.2%) |
June 2010 | - | -378.17%(+10.4%) |
Mar 2010 | - | -342.51%(+74.1%) |
Dec 2009 | -427.60%(-25.7%) | -196.72%(-57.3%) |
Sept 2009 | - | -460.22%(-61.6%) |
June 2009 | - | -1197.89%(+125.0%) |
Mar 2009 | - | -532.35%(-4.3%) |
Dec 2008 | -575.47%(-22.3%) | -556.04%(+22.2%) |
Sept 2008 | - | -454.86%(-42.6%) |
June 2008 | - | -793.08%(+32.2%) |
Mar 2008 | - | -600.02%(-19.1%) |
Dec 2007 | -740.89%(-53.3%) | -742.01%(-15.8%) |
Sept 2007 | - | -881.30%(+7.1%) |
June 2007 | - | -823.23%(+63.5%) |
Mar 2007 | - | -503.62%(-54.0%) |
Dec 2006 | -1587.26%(-85.1%) | -1095.13%(+3.8%) |
Sept 2006 | - | -1055.53%(-63.0%) |
June 2006 | - | -2853.85%(-43.1%) |
Mar 2006 | - | -5012.27%(-21.8%) |
Dec 2005 | -10.66 K%(+6527.8%) | -6406.95%(-56.4%) |
Sept 2005 | - | -14.68 K%(+127.8%) |
June 2005 | - | -6445.22%(>+9900.0%) |
Dec 2002 | - | -34.67%(-54.0%) |
Sept 2002 | - | -75.32%(-67.7%) |
June 2002 | - | -233.47%(-645.4%) |
Mar 2002 | - | 42.81% |
Dec 2001 | -160.85% | - |
FAQ
- What is Halozyme Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual operating margin year-on-year change?
- What is Halozyme Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly operating margin year-on-year change?
What is Halozyme Therapeutics annual operating profit margin?
The current annual operating margin of HALO is 40.71%
What is the all time high annual operating margin for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual operating profit margin is 62.24%
What is Halozyme Therapeutics annual operating margin year-on-year change?
Over the past year, HALO annual operating profit margin has changed by +0.18% (+0.44%)
What is Halozyme Therapeutics quarterly operating profit margin?
The current quarterly operating margin of HALO is 56.26%
What is the all time high quarterly operating margin for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly operating profit margin is 68.19%
What is Halozyme Therapeutics quarterly operating margin year-on-year change?
Over the past year, HALO quarterly operating profit margin has changed by +15.40% (+37.69%)